Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Microsoft
MSFT
|
+$834M |
| 2 |
Apple
AAPL
|
+$763M |
| 3 |
Amazon
AMZN
|
+$604M |
| 4 |
Meta Platforms (Facebook)
META
|
+$293M |
| 5 |
Johnson & Johnson
JNJ
|
+$263M |
Top Sells
| 1 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$52.4M |
| 2 |
ZAYO
Zayo Group Holdings, Inc.
ZAYO
|
+$32.8M |
| 3 |
LPT
Liberty Property Trust
LPT
|
+$29.6M |
| 4 |
MDCO
Medicines Co
MDCO
|
+$12.9M |
| 5 |
INXN
Interxion Holding N.V.
INXN
|
+$12.3M |
Sector Composition
| 1 | Technology | 23.53% |
| 2 | Healthcare | 15.94% |
| 3 | Consumer Discretionary | 11.41% |
| 4 | Communication Services | 10.49% |
| 5 | Consumer Staples | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2001
QuinStreet
QNST
$934M
| $719K | ﹤0.01% |
89,300
+1,600
| +2% | +$12.9K |
|
|
EBIX
2002
DELISTED
Ebix Inc
EBIX
| $718K | ﹤0.01% |
47,300
+600
| +1% | +$9.11K |
|
2003
Axogen
AXGN
$753M
| $717K | ﹤0.01% |
68,900
+1,300
| +2% | +$13.5K |
|
2004
Boot Barn
BOOT
$5.55B
| $716K | ﹤0.01% |
55,400
+900
| +2% | +$11.6K |
|
2005
Winmark
WINA
$1.77B
| $714K | ﹤0.01% |
5,600
+500
| +10% | +$63.8K |
|
|
ATRS
2006
DELISTED
Antares Pharma, Inc.
ATRS
| $710K | ﹤0.01% |
300,700
+4,200
| +1% | +$9.92K |
|
|
EIDX
2007
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $710K | ﹤0.01% |
14,500
+400
| +3% | +$19.6K |
|
2008
ANI Pharmaceuticals
ANIP
$2.14B
| $709K | ﹤0.01% |
17,400
| – | – |
|
2009
First Financial Corporation Common Stock
THFF
$687M
| $709K | ﹤0.01% |
21,026
| – | – |
|
2010
Fortuna Silver Mines
FSM
$2.52B
| $706K | ﹤0.01% |
312,000
+4,400
| +1% | +$9.96K |
|
2011
E.W. Scripps
SSP
$248M
| $706K | ﹤0.01% |
93,616
+1,200
| +1% | +$9.05K |
|
2012
Bank of Marin Bancorp
BMRC
$393M
| $705K | ﹤0.01% |
23,500
| – | – |
|
|
MNTV
2013
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $705K | ﹤0.01% |
52,200
+1,300
| +3% | +$17.6K |
|
2014
Adtran
ADTN
$836M
| $703K | ﹤0.01% |
91,500
| – | – |
|
2015
Banc of California
BANC
$2.61B
| $703K | ﹤0.01% |
87,900
+1,100
| +1% | +$8.8K |
|
2016
MGP Ingredients
MGPI
$591M
| $702K | ﹤0.01% |
26,100
| – | – |
|
2017
Upwork
UPWK
$2.22B
| $700K | ﹤0.01% |
108,600
+2,600
| +2% | +$16.8K |
|
2018
Star Group
SGU
$386M
| $699K | ﹤0.01% |
90,803
+1,500
| +2% | +$11.5K |
|
2019
Clearwater Paper
CLW
$345M
| $698K | ﹤0.01% |
32,000
+1,000
| +3% | +$21.8K |
|
|
ATNX
2020
DELISTED
Athenex, Inc. Common Stock
ATNX
| $698K | ﹤0.01% |
4,510
+75
| +2% | +$11.6K |
|
2021
Flushing Financial
FFIC
$474M
| $694K | ﹤0.01% |
51,923
+700
| +1% | +$9.36K |
|
2022
Catalyst Pharmaceutical
CPRX
$2.42B
| $693K | ﹤0.01% |
179,900
+2,600
| +1% | +$10K |
|
2023
Zumiez
ZUMZ
$343M
| $693K | ﹤0.01% |
40,000
+600
| +2% | +$10.4K |
|
2024
Origin Bancorp
OBK
$1.1B
| $692K | ﹤0.01% |
34,182
+500
| +1% | +$10.1K |
|
2025
Waterstone Financial
WSBF
$284M
| $692K | ﹤0.01% |
47,600
| – | – |
|